SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-May-24 7:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-May-24 | Payment of Exercise | 26,082 | $10.01 | $261,081.00 | (3%) 834.82K to 808.74K | |
03-May-24 6:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-May-24 | Conversion | 21,296 | -- | -- | 2% 863.52K to 884.82K | |
03-May-24 6:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-May-24 | Sale (Planned) | 50,000 | $8.47 | $423,500.00 | (6%) 884.82K to 834.82K | |
03-May-24 6:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-May-24 | Gift | 25,000 | -- | -- | (3%) 938.52K to 913.52K | |
03-May-24 6:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-May-24 | Sale (Planned) | 50,000 | $7.73 | $386,500.00 | (5%) 913.52K to 863.52K | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 04-Apr-24 | Conversion | 25,000 | -- | -- | 3% 978.52K to 1.0M | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 04-Apr-24 | Sale (Planned) | 40,000 | $9.02 | $360,800.00 | (4%) 1.0M to 963.52K | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 04-Apr-24 | Sale (Planned) | 25,000 | $9.02 | $225,500.00 | (3%) 963.52K to 938.52K | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-24 | Conversion | 25,000 | -- | -- | 2% 1.04M to 1.07M | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-24 | Gift | 25,000 | -- | -- | (2%) 1.07M to 1.04M | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-24 | Sale (Planned) | 40,000 | $8.84 | $353,600.00 | (4%) 1.04M to 1.0M | |
05-Apr-24 5:44 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-24 | Sale (Planned) | 25,000 | $8.84 | $221,000.00 | (2%) 1.0M to 978.52K | |
01-Apr-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Mar-24 | Conversion | 25,000 | -- | -- | 2% 1.11M to 1.13M | |
01-Apr-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Mar-24 | Gift | 25,000 | -- | -- | (2%) 1.13M to 1.11M | |
01-Apr-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Mar-24 | Sale (Planned) | 40,000 | $10.10 | $404,000.00 | (4%) 1.11M to 1.07M | |
01-Apr-24 6:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Mar-24 | Sale (Planned) | 25,000 | $10.10 | $252,500.00 | (2%) 1.07M to 1.04M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Conversion | 10,000 | -- | -- | < 1% 1.1M to 1.11M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Conversion | 25,000 | -- | -- | 2% 1.11M to 1.14M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Gift | 10,000 | -- | -- | (< 1%) 1.18M to 1.17M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Option Exercise | 39,924 | $4.42 | $176,384.00 | 4% 1.14M to 1.18M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Planned Option Sale | 36,319 | $11.86 | $430,682.00 | (3%) 1.17M to 1.13M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Planned Option Sale | 3,605 | $11.55 | $41,648.30 | (< 1%) 1.13M to 1.13M | |
08-Mar-24 7:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Mar-24 | Sale (Planned) | 21,395 | $11.55 | $247,175.00 | (2%) 1.13M to 1.11M | |
16-Feb-24 7:57 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Feb-24 | Payment of Exercise | 11,148 | $12.43 | $138,570.00 | (< 1%) 1.12M to 1.1M | |
13-Feb-24 6:55 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Grant | 344,597 | -- | -- | 44% 774.7K to 1.12M | |
13-Feb-24 6:55 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Feb-24 | Payment of Exercise | 3,233 | $10.09 | $32,621.00 | (< 1%) 1.12M to 1.12M | |
09-Feb-24 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-24 | Conversion | 10,000 | -- | -- | 1% 791.73K to 801.73K | |
09-Feb-24 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-24 | Gift | 10,000 | -- | -- | (1%) 832.98K to 822.98K | |
09-Feb-24 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-24 | Option Exercise | 31,250 | $2.48 | $77,500.00 | 4% 801.73K to 832.98K | |
09-Feb-24 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-24 | Planned Option Sale | 31,250 | $9.22 | $288,069.00 | (4%) 822.98K to 791.73K | |
09-Feb-24 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-24 | Sale (Planned) | 17,022 | $9.22 | $156,912.00 | (2%) 791.73K to 774.7K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Conversion | 10,000 | -- | -- | 1% 791.33K to 801.33K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Conversion | 25,000 | -- | -- | 3% 801.33K to 826.33K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Gift | 10,000 | -- | -- | (1%) 857.58K to 847.58K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Option Exercise | 31,250 | $2.48 | $77,500.00 | 4% 826.33K to 857.58K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Planned Option Sale | 30,853 | $9.49 | $292,804.00 | (4%) 847.58K to 816.73K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Planned Option Sale | 397 | $9.51 | $3,775.68 | (< 1%) 816.73K to 816.33K | |
05-Jan-24 8:03 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-24 | Sale (Planned) | 24,603 | $9.51 | $233,987.00 | (3%) 816.33K to 791.73K | |
08-Dec-23 5:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Dec-23 | Conversion | 10,000 | -- | -- | 1% 819.91K to 829.91K | |
08-Dec-23 5:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Dec-23 | Gift | 10,000 | -- | -- | (1%) 861.16K to 851.16K | |
08-Dec-23 5:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Dec-23 | Option Exercise | 31,250 | $2.48 | $77,500.00 | 4% 829.91K to 861.16K | |
08-Dec-23 5:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Dec-23 | Planned Option Sale | 31,250 | $7.49 | $234,206.00 | (4%) 851.16K to 819.91K | |
08-Dec-23 5:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Dec-23 | Sale (Planned) | 28,579 | $7.49 | $214,188.00 | (3%) 819.91K to 791.33K | |
17-Nov-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 15-Nov-23 | Payment of Exercise | 16,913 | $7.18 | $121,435.00 | (2%) 836.82K to 819.91K | |
17-Nov-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Nov-23 | Conversion | 10,000 | -- | -- | 1% 836.82K to 846.82K | |
17-Nov-23 5:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Nov-23 | Gift | 10,000 | -- | -- | (1%) 846.82K to 836.82K | |
03-Nov-23 6:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Nov-23 | Conversion | 25,000 | -- | -- | 3% 842.75K to 867.75K | |
03-Nov-23 6:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Nov-23 | Option Exercise | 31,250 | $2.48 | $77,500.00 | 4% 867.75K to 899.0K | |
03-Nov-23 6:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Nov-23 | Planned Option Sale | 31,250 | $5.20 | $162,488.00 | (3%) 899.0K to 867.75K | |
03-Nov-23 6:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Nov-23 | Sale (Planned) | 5,927 | $5.20 | $30,818.00 | (< 1%) 867.75K to 861.82K |